Skip to content
DraconiticResearch
Search Sources API
178,033 studies31 sourcesUpdated 18 min ago
Peer-reviewedCC BY 4.0Frontiers in Immunology

The role of 18F-FDG PET-CT in predicting progressive pulmonary fibrosis in idiopathic inflammatory myopathy associated interstitial lung disease

7 affiliations
  1. 1Department of General Medicine/Internal Medicine, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine
  2. 2Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine
  3. 3Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine
  4. 4Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine
  5. 5Shanghai Key Laboratory of Emergency Prevention, Diagnosis and Treatment of Respiratory Infectious Diseases
  6. 6Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine
  7. 7Department of Dermatology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine

Abstract

Aim: This study aims to investigate the role of ¹⁸ F-FDG PET-CT in the development of progressive pulmonary fibrosis (PPF) in patients with idiopathic inflammatory myopathy-associated interstitial lung disease (IIM-ILD) and to develop a predictive nomogram model.

Methods: This study retrospectively included patients diagnosed with IIM-ILD who underwent ¹⁸ F-FDG PET-CT at Ruijin Hospital between 2018 and 2024. The baseline characteristics, IIM types, myositis antibodies, laboratory tests, pulmonary function, ILD subtypes, ¹⁸ F-FDG PET-CT findings, and treatment were collected. Enrolled patients were divided into PPF and non-PPF groups according to diagnostic criteria. Clinical features were compared between the two groups, and logistic regression analysis was performed to identify risk factors for PPF. All identified risk factors were combined to construct the predictive nomogram. Receiver operating characteristic curve, calibration plot, and decision curve analysis were used to evaluate the accuracy and efficiency of this predictive model. Additionally, we drew the survival curve of PPF and non-PPF, and compared the maximum standardized uptake value (SUV max ) between short-term death and long-term survival.

Results: A total of 71 eligible IIM-ILD patients were included, of whom 29 developed PPF within one year of follow-up. Multivariate analysis revealed that bilateral lung SUV max and FVC%pred were associated with the occurrence of PPF. The calibration plot demonstrated excellent agreement between the predicted and actual observed probability of PPF (Hosmer–Lemeshow test: P = 0.143). The predictive nomogram achieved an area under the curve of 0.887 (95% CI : 0.805–0.969). The SUV max in the lungs was significantly higher in the PPF group than in the non-PPF group ( P < 0.001). Moreover, lung SUVmax was significantly higher in patients who died within one year than in those who survived for more than five years ( P = 0.014). In addition, patients with PPF had a significantly lower survival rate than those without PPF ( P = 0.040).

Conclusion: ¹⁸ F-FDG PET-CT and FVC% pred are associated with the occurrence of PPF. The prognosis of PPF is poor, and high SUV max is correlated with short-term mortality. Exhibiting robust discrimination and calibration, this nomogram holds potential for clinical application.

Related

  1. Clinical variables and quantitative CT radiomics for mortality risk stratification after acute exacerbation of idiopathic inflammatory myopathy-associated interstitial lung disease
    Liyu He, Yanrong Chen, Jingping Zhang +6
    Frontiers in immunologyPeer-reviewedCC BYFull textImmunologyEurope PMCCrossref
  2. Accuracy of CSF tap test and lumbar infusion test in predicting shunt response in idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis
    Aminu Aliyar, Deepa Dash, Alfonso Fasano +8
    Frontiers in NeurologyPeer-reviewedCC BY 4.0Full textNeuroscienceCrossrefPMC
  3. Free Mitochondrial DNA and Mitophagy Dysfunction in Diabetic Kidney Disease: A Central Mitochondrial-Inflammatory Axis Driving Progressive Renal Injury.
    Aasthika Das, Eric Lalu, Vikky Awasthi +7
    CellsPeer-reviewedCC BYFull textCell biologyEurope PMC
  4. Correlative and Live-Cell Imaging of S100B-Promoter-Associated Interstitial Cells from the Cardiac Sinoatrial Node and Valves
    Dmitry B. Zorov, Miguel Calvo-Rubio, Robert E. Monticone +10
    CellsPeer-reviewedCC BYFull textCell biologyEurope PMC
  5. Serum concentration of Surfactant protein D at diagnosis is associated with malnutrition in patients with idiopathic pulmonary fibrosis
    Laurent Vernhet, Cédric Ménard, Chloe Rousseau +1
    Respiratory Medicine and ResearchPeer-reviewedCC BY-NC 4.0Full textGeneral biologyHAL
BibTeX
@article{sun2026role,
  title = {{The role of 18F-FDG PET-CT in predicting progressive pulmonary fibrosis in idiopathic inflammatory myopathy associated interstitial lung disease}},
  author = {Chao Sun and Ze Zhang and Qianqian Zhao and Lin Huang and Jiaxin Tian and Wenxin Wu and Yijie Li and Jialin Teng and Hua Cao and Min Zhou},
  journal = {Frontiers in Immunology},
  year = {2026},
  month = oct,
  doi = {10.3389/fimmu.2026.1862578},
  url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1862578/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - The role of 18F-FDG PET-CT in predicting progressive pulmonary fibrosis in idiopathic inflammatory myopathy associated interstitial lung disease
AU  - Chao Sun
AU  - Ze Zhang
AU  - Qianqian Zhao
AU  - Lin Huang
AU  - Jiaxin Tian
AU  - Wenxin Wu
AU  - Yijie Li
AU  - Jialin Teng
AU  - Hua Cao
AU  - Min Zhou
PY  - 2026
DA  - 2026/10/29
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1862578
UR  - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1862578/full
AB  - Aim: This study aims to investigate the role of ¹⁸ F-FDG PET-CT in the development of progressive pulmonary fibrosis (PPF) in patients with idiopathic inflammatory myopathy-associated interstitial lung disease (IIM-ILD) and to develop a predictive nomogram model.  Methods: This study retrospectively included patients diagnosed with IIM-ILD who underwent ¹⁸ F-FDG PET-CT at Ruijin Hospital between 2018 and 2024. The baseline characteristics, IIM types, myositis antibodies, laboratory tests, pulmonary function, ILD subtypes, ¹⁸ F-FDG PET-CT findings, and treatment were collected. Enrolled patients were divided into PPF and non-PPF groups according to diagnostic criteria. Clinical features were compared between the two groups, and logistic regression analysis was performed to identify risk factors for PPF. All identified risk factors were combined to construct the predictive nomogram. Receiver operating characteristic curve, calibration plot, and decision curve analysis were used to evaluate the accuracy and efficiency of this predictive model. Additionally, we drew the survival curve of PPF and non-PPF, and compared the maximum standardized uptake value (SUV max ) between short-term death and long-term survival.  Results: A total of 71 eligible IIM-ILD patients were included, of whom 29 developed PPF within one year of follow-up. Multivariate analysis revealed that bilateral lung SUV max and FVC%pred were associated with the occurrence of PPF. The calibration plot demonstrated excellent agreement between the predicted and actual observed probability of PPF (Hosmer–Lemeshow test: P = 0.143). The predictive nomogram achieved an area under the curve of 0.887 (95% CI : 0.805–0.969). The SUV max in the lungs was significantly higher in the PPF group than in the non-PPF group ( P < 0.001). Moreover, lung SUVmax was significantly higher in patients who died within one year than in those who survived for more than five years ( P = 0.014). In addition, patients with PPF had a significantly lower survival rate than those without PPF ( P = 0.040).  Conclusion: ¹⁸ F-FDG PET-CT and FVC% pred are associated with the occurrence of PPF. The prognosis of PPF is poor, and high SUV max is correlated with short-term mortality. Exhibiting robust discrimination and calibration, this nomogram holds potential for clinical application.
SN  - 1664-3224
ER  -